Ischemic stroke (IS) due to giant cell arteritis (GCA) is rare, but highly mortal.
Introduction
Cerebrovascular ischemic strokes (IS), which have been reported in 4 -6 % of patients with giant cell arteritis (GCA), are the leading cause of mortality. 1 Here we report a case of frequent IS due to GCA which usually develops a serious course, but was rescued by multi-modal therapy with corticosteroids, immunosuppressive agents, antiplatelets, and statin.
Case report
A man had been on medication for diabetes and hyperlipidemia from the age of 45. When he was 72 years old, he suddenly experienced dysarthria and right hemiparesis, which spontaneously disappeared 90 min after onset. Upon visiting our emergency clinic, he was admitted to our hospital. He showed a normal body temperature (36.1 ℃) and no neurological deficits. Laboratory tests revealed a moderately elevated erythrocyte sedimentation rate (ESR, 38/71 mm). Brain magnetic resonance imaging (MRI) showed no high intensity area (HIA) with diffusion-weighted image (DWI, Fig. 1Aa ). On the other hand, MR angiography (MRA) showed severe stenosis at the supraclinoid portion of the bilateral internal carotid arteries (ICAs, Fig. 1Ab , arrows). On day 4 of admission, he again presented transient right hemiparesis, when DWI showed HIA in the left frontal lobe ( Fig.  1Ac , arrows), and was thus temporarily diagnosed with atherothrombotic stroke. He was discharged on day 28 after prescribing aspirin (100 mg) and pravastatin (5 mg).
However, he experienced transient aphasia and right upper limb paresis without any new lesions on DWI at 7 days after discharge, and was again admitted to our hospital.
Based on recurrent IS with persistently high inflammatory responses, we suspected cervical/intracranial vasculitis. Gadolinium (Gd)-enhanced brain MRI showed intramural enhancement in both terminal ICAs ( Fig. 1Ad , e, arrowheads) and in the superficial temporal artery (STA) ( Fig. 1Af , g, arrowheads). T2 star-weighted image (T2 * WI) showed no intracranial microbleeds (not shown). Digital subtraction angiography (DSA) showed that the smoothly tapered vascular stenosis at the supraclinoid portions of ICA ( Fig. 1B , arrow) without middle cerebral artery (MCA) stenosis, and the decreased blood flow velocity in distal part from the supraclinoid portions. A 18 F-fluoro-2-deoxy-2-d-glucose ( 18 F-FDG) positron emission tomography (PET)/computed tomography (CT) scan showed increased uptake in bilateral common carotid arteries, the right subclavian artery, and the aortic arch ( Fig. 1Ca-d, arrows ). An STA biopsy on day 12 of the second admission showed significant intimal thickening (Fig. 1Da , arrows), epithelioid granuloma ( Fig. 1Db, arrows) , and giant cell formation ( Fig. 1Dc , arrows).
The patient was thus diagnosed with recurrent IS due to GCA, and was treated with prednisolone (PSL, 60 mg) and cyclophosphamide (CPA, 500 mg). Although ESR decreased immediately to a normal range after this combination therapy, carotid artery ultrasound showed a gradual increase of intima-media thickness (IMT) and a reduction in end diastolic velocity (EDV) of the ICA (Fig. 1E, upper columns) . He developed at least 10 TIAs and four strokes ( Fig. 1E , middle column) within 4 weeks, and his gait disturbance and frontal lobe function gradually worsened (frontal assessment battery (FAB); from 17/18 on the second admission to 5/18 on day 35). However, such frequent ischemic attacks disappeared soon after replacing pravastatin (5 mg) with atorvastatin (10 mg) on day 47 followed by antiplatelet oral cilostazol (50 -100 mg) and ozagrel infusion (80 mg) from day 53, and methotrexate (6 mg/week) from day 66. On day 108, he was discharged, walked independently, and FAB recovered to 17/18.
Discussion
The present case showed frequent IS with intracranial artery stenosis due to GCA, but was successfully rescued by combination therapy of steroids, immunosuppressants, antiplatelets, and statin. Although the present case had not showed typical clinical symptoms of GCA such as headache, jaw claudiation, and enlarged temporal artery, these symptoms' sensitivities were low. 2 The positive temporal artery biopsy and the findings of inflammatory in the large arteries on MRI and 18 F-FDG PET/CT scan were also important 6 findings for meeting the criteria of GCA as well as specific clinical symptoms. 3 Thus, he was diagnosed with GCA.
MRA of the present case depicted poorer MCA related with worsened his symptoms. On the other hand, DSA showed the severe stenosis at the supraclinoid portions of ICA without MCA stenosis (Fig. 1B, arrow) . Decreased arterial signal on MCA might be caused by the hypoperfusion of MCA due to ICA stenosis. Furthermore, the reversible arterial wall thickening after treatment on enhanced MRI suggested vasculitis (Fig. 1E , lower column). Although cerebral infarction at corona radiate was atypical for GCA, the previous report showed that partial internal watershed infarction was associated with hemodynamic impairment with ICA steno-occlusion. 4 These results suggested that the main pathological mechanism of the present case was hemodynamic etiology caused by bilateral ICA stenosis due to GCA.
High-dose glucocorticoid therapy is well established for the treatment of IS due to GCA, and antiplatelet and statin therapy may also be effective. 5, 6 However, in the present case, IS frequency increased and both IMT and EDV worsened (Fig. 1E) , even after steroid therapy. Steroid therapy might not rapidly improve the organized intima thickening, may even activate platelet thromboxane, and promotes vascular occlusion. 7 On the other hand, a combination of corticosteroids plus immunosuppressive agents or antiplatelet therapy appears to be beneficial in patients with IS due to GCA. 1, 5 Furthermore, 7 cilostazol shows not only an antiplatelet but also a vasodilatory effect by inhibiting phosphodiesterase 3, subsequently raising the level of intracellular cAMP. 8 In fact, the present case showed a gradual improvement of IMT and EDV ultrasound findings as well as improved symptoms after continuous multi-modal therapy including additional cilostazol therapy (50 -100 mg) ( Fig. 1E ). Although the second administration of cyclophosphamide might be effective, the first administration of cyclophosphamide was not effective. Therefore, we considered that the vasodilatory effect of cilostazol was clinically more effective.
IS due to GCA is rare and shows a mortality rate as high as 53%. 1 However, the present case suggests that multi-modal combination therapy was able to rescue GCA patient with frequent IS with ITAs and lacunes. 
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